✦ LIBER ✦

Cyclin D1, a Novel Molecular Marker of Minimal Residual Disease, in Metastatic Neuroblastoma

✍ Scribed by Cheung, Irene Y.; Feng, Yi; Vickers, Andrew; Gerald, William; Cheung, Nai-Kong V.

Book ID: 122530536
Publisher: American Society for Investigative Pathology
Year: 2007
Tongue: English
Weight: 193 KB
Volume: 9
Category: Article
ISSN: 1525-1578
DOI: 10.2353/jmoldx.2007.060130

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sialyltransferase STX (ST8SiaII): A nove

Sialyltransferase STX (ST8SiaII): A novel molecular marker of metastatic neuroblastoma

✍ Irene Y. Cheung; Andrew Vickers; Nai-Kong V. Cheung 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 123 KB

## Abstract Polysialic acid (PSA) is highly expressed in many human cancers, including neuroblastoma (NB), and is critical for cellular adhesion, neuronal migration and tumor metastasis. The key enzyme responsible for PSA synthesis is sialyltransferase STX (ST8SiaII). Using quantitative RT‐PCR we (

Quantitative monitoring of cyclin D1 exp

Quantitative monitoring of cyclin D1 expression: A molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma

✍ Helena Brizova; Marketa Kalinova; Lenka Krskova; Marcela Mrhalova; Roman Kodet 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 235 KB

## Abstract In mantle cell lymphoma (MCL), minimal residual disease (MRD) is an indicator of the disease outcome. Quantitative methods used so far do not provide a suitable molecular marker in 30–70% patients with MCL (depending on the technique used). We tested cyclin D1 as a marker for quantitati

Mammaglobin A, a novel marker of minimal

Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer

✍ F Janku; Z Kleibl; J Novotny; P Tesarova; L Petruzelka; M Safanda; P Mares; M Ze 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Molecular assessment of minimal residual

Molecular assessment of minimal residual disease in PBSC harvests provides prognostic information in neuroblastoma

✍ Chambon, F.; Tchirkov, A.; Pereira, B.; Rochette, E.; Deméocq, F.; Kanold, J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

Stability of PCR Targets for Monitoring

Stability of PCR Targets for Monitoring Minimal Residual Disease in Neuroblastoma

✍ Stutterheim, Janine; Zappeij-Kannegieter, Lily; Ãra, Ingrid; van Sluis, Peter G 📂 Article 📅 2012 🏛 American Society for Investigative Pathology 🌐 English ⚖ 884 KB

Outcome prediction by molecular detectio

Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma

✍ Horibe, Keizo ;Fukuda, Minoru ;Miyajima, Yuji ;Matsumoto, Kimikazu ;Kondo, Masar 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Background. We have determined whether sequential molecular detection of minimal residual disease (MRD) in bone marrow (BM) could predict the outcome of patients with advanced neuroblastoma (NB). Procedure. Bone marrow samples from 19 patients over 12 months of age with stage 4 neuroblastoma were se